CareDx Inc (NASDAQ: CDNA) is -13.41% lower on its value in year-to-date trading and has touched a low of $8.10 and a high of $41.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDNA stock was last observed hovering at around $9.84 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $9.88, the stock is -23.06% and -27.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.86 million and changing 0.41% at the moment leaves the stock -44.20% off its SMA200. CDNA registered -64.95% loss for a year compared to 6-month loss of -46.57%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The stock witnessed a -34.40% gain in the last 1 month and extending the period to 3 months gives it a -21.90%, and is -7.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.02% over the week and 11.96% over the month.
CareDx Inc (CDNA) has around 727 employees, a market worth around $558.71M and $321.80M in sales. Profit margin for the company is -23.80%. Distance from 52-week low is 21.98% and -76.19% from its 52-week high. The company has generated returns on investments over the last 12 months (-18.00%).
CareDx Inc (CDNA) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for CareDx Inc (CDNA) is a “Overweight”. 7 analysts offering their recommendations for the stock have an average rating of 2.30, where 4 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
CareDx Inc is expected to release its quarterly report on 05/04/2023.The EPS is expected to shrink by -144.80% this year
CareDx Inc (CDNA) Top Institutional Holders
The shares outstanding are 53.53M, and float is at 52.24M with Short Float at 9.35%.
CareDx Inc (CDNA) Insider Activity
A total of 42 insider transactions have happened at CareDx Inc (CDNA) in the last six months, with sales accounting for 22 and purchases happening 20 times. The most recent transaction is an insider sale by Seeto Reginald, the company’s. SEC filings show that Seeto Reginald sold 2,819 shares of the company’s common stock on Mar 02 at a price of $15.88 per share for a total of $44758.0. Following the sale, the insider now owns 0.54 million shares.
CareDx Inc disclosed in a document filed with the SEC on Feb 10 that Seeto Reginald () sold a total of 8,488 shares of the company’s common stock. The trade occurred on Feb 10 and was made at $15.48 per share for $0.13 million. Following the transaction, the insider now directly holds 0.54 million shares of the CDNA stock.
Still, SEC filings show that on Feb 09, Seeto Reginald () disposed off 11,094 shares at an average price of $16.13 for $0.18 million. The insider now directly holds 551,940 shares of CareDx Inc (CDNA).
CareDx Inc (CDNA): Who are the competitors?
The company’s main competitors (and peers) include Agios Pharmaceuticals Inc. (AGIO) that is -11.43% lower over the past 12 months. T2 Biosystems Inc. (TTOO) is -97.10% down on the 1-year trading charts.